Optiver Holding
NRIX icon

Optiver Holding’s Nurix Therapeutics NRIX Stock Holding History

Optiver Holding’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8K Buy
570
+214
+60% +$3.65K ﹤0.01% 1658
2026
Q1 		$5.52K Sell
356
-152
-30% -$2.52K ﹤0.01% 1382
2025
Q4 		$9.64K Buy
508
+108
+27% +$1.55K ﹤0.01% 1155
2025
Q3 		$3.7K Buy
+400
New +$4.15K ﹤0.01% 2025

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Optiver Holding's NRIX Position: Q2 2026 in Review

Optiver Holding increased its Nurix Therapeutics (NRIX) stake by 60% in Q2 2026, buying an estimated $3.65K and bringing the position to 570 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1658.

Optiver Holding first reported a position in NRIX in Q3 2025 and has held it in 4 quarters since. 211 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • Optiver Holding held 570 shares of Nurix Therapeutics worth $13.8K as of Q2 2026.
  • Optiver Holding bought 214 Nurix Therapeutics shares in Q2 2026, an estimated $3.65K.
  • Nurix Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1658 holding.
  • Optiver Holding first reported a position in Nurix Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 211 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.